About the Role
Fasikl is an innovative medical technology company focused on delivering non-invasive, AI-driven neuromodulation solutions. Our flagship product is FDA-cleared to aid in functional limitations due to essential tremor. As we expand access to it through Medicare, commercial insurers, and direct-to-patient channels, we are seeking a Billing Specialist to support our end-to-end revenue cycle operations.
Key Responsibilities
- Manage all claims submission, follow-up, denial management, and patient billing processes for DMEPOS services.
- Ensure accuracy and compliance in coding (HCPCS), modifiers, and payer-specific rules across all channels (Medicare, private insurance, self-pay).
- Develop and refine scalable billing workflows and documentation requirements in partnership with customer service, clinical, and fulfillment teams.
- Monitor and resolve claims denials, rejections, and delays; manage appeals processes to maximize reimbursement.
- Manage payer enrollment, credentialing, and policy updates for DMEPOS billing.
- Track and report on key revenue cycle metrics, including DSO, collections, aging, and denial trends.
- Contribute to the evaluation and implementation of billing software, clearinghouses, and internal tracking tools to improve efficiency and transparency.
- Collaborate with leadership on pricing strategy, payer contracting, and reimbursement policy changes.
- Ensure HIPAA and CMS regulatory compliance in all billing activities.
- What We’re Looking For
- Bachelor’s degree in healthcare administration, business, or related field required.
- 3+ years of medical billing and reimbursement experience required.
- Deep understanding of DMEPOS billing, Medicare guidelines, and commercial insurance workflows.
- Strong knowledge of HCPCS coding, payer rules, CMS documentation standards, and revenue cycle best practices.
- Experience working with billing software/ERP tools.
About Fasikl
Fasikl is a NeuroAI company spun out of the University of Minnesota that develops AI-based therapies for neurological conditions. Its Felix NeuroAI Wristband is an FDA-cleared, non-invasive treatment designed to reduce hand tremors in people with essential tremor.
- HQ
- Bloomington, MN
- Team
- 11–50
- Founded
- 2019
- Raised
- $60M
- Last round
- Series B
Backed by iSeed Ventures, Tailwind Ventures, Qiming Venture Partners
Fasikl in the Cortex
Why Join
- Develops AI therapeutics focused on neurological conditions.
- The Felix NeuroAI Wristband is a non-invasive treatment for essential tremor.
- The wristband is described as FDA-cleared to reduce hand tremors.
- Builds on more than 20 years of neural engineering research and innovation.
Skills & Tech
Know someone perfect for this role?
Share this opportunity with your network